Cholelithiasis

07/02/2020 - "These results are helpful in exploring new lipid metabolism pathways and potential targets for the treatment of cholesterol stones and for providing some basis for the study of the pathogenesis and genetic characteristics of cholelithiasis. "
08/01/1998 - "Effects of UDC on secretory low-molecular-weight PLA2s as inflammatory mediators may relate to the reported efficacy of UDC treatment in cholesterol gallstone disease."
08/01/2021 - "The aim of the present study was to investigate changes in gallbladder ICCs during the development of cholesterol cholelithiasis. "
04/01/2021 - "Taken together, results from the present study suggest that YCHD ameliorated LD-induced cholelithiasis mice, which may be caused by improvements in biliary cholesterol supersaturation and regulation of cholesterol metabolism."
02/04/2019 - "This study aimed to examine the risk of symptomatic gallstone disease (GSD) in Taiwanese vegetarians vs. nonvegetarians in a prospective cohort and to explore if this association is related to cholesterol concentration. "

02/01/1993 - "[Computed X-ray tomography in predicting the efficacy of oral cholelithiasis with bile acids]."
01/01/2021 - "In this study, ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry (UPLC-MS/MS) was used to analyze the 15 types of serum bile acid profiles among patients with ICP in third trimester, patients with cholelithiasis, and patients with hepatitis B virus. "
03/01/1985 - "Studies on the effects of pH and bile acids in regard to its role in the pathogenesis of cholelithiasis."
09/01/1984 - "These approaches to the structural chemistry of bile salt intra- and intermolecular interactions are providing the basis for the design of artificial bile salt-like compounds for use in the study and treatment of human gallstone disease."
01/01/2021 - "Bile acid metabolism is a contributing factor that promotes cholelithiasis. "

11/01/2021 - "Ursodeoxycholic acid is used in human medicine for litholytic management of choleliths, but the efficacy of medical management in dogs with cholelithiasis is unknown. "
01/01/2023 - "This study aimed to examine prescription patterns for ursodiol and reassess its impact on gallstone disease using a large administrative database. "
01/01/2005 - "Two additional infants (not in the original study) with TPN-associated gallstone disease were also given a trial of ursodeoxycholic acid. "
01/01/2023 - "The primary outcome was gallstone disease within 1 year, which was compared between patients who did and did not receive an ursodiol prescription. "
01/01/2023 - "Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey."

03/01/1994 - "Asymptomatic stones were recorded in 13/49 patients (26.5%) prior to octreotide treatment (the prevalence of cholelithiasis in the Italian population is 9.5% in men and 18.9% in women). "
02/01/1994 - "We sought to examine the feasibility of intermittent dosing of octreotide in acromegalics to avoid the well-documented side effect of cholelithiasis. "
01/01/1994 - "Two patients, however, suffered from recurrent malaise and reduced octreotide doses (one case, who also developed cholelithiasis), or refused to continue the treatment. "
11/01/1993 - "The wide spectrum of effects of octreotide in humans accounts for adverse effects seen during long term treatment, primarily cholelithiasis. "
09/01/1993 - "We sought to examine how the discontinuation of octreotide in long-term octreotide-treated acromegalic patients affects the well-documented side-effect of cholelithiasis. "

10/01/2016 - "In the present study, we investigated expression pattern of Cholecystokinin type A receptor (CCKAR) in relation to its commonly studied polymorphism (rs1800857, T/C) in gallstone disease (GSD) patients and controls. "
10/01/2016 - "Polymorphism and Expression Profile of Cholecystokinin Type A Receptor in Relation to Gallstone Disease Susceptibility."
06/01/1998 - "Seventy-eight patients with an abnormal GEF (< 35%) on cholecystokinin hepatobiliary scan without cholelithiasis were studied retrospectively. "
04/01/1997 - "Different pathways mediate cholecystokinin actions in cholelithiasis."
09/01/1987 - "Duodenal fluid was collected from patients with suspected cholelithiasis (n = 10) before and after pancreozymin-cholecystokinin injection. "

01/01/2023 - "This study aimed to elucidate the association between ABCG5/G8 gene region variants and lipid profile, cardiometabolic traits, and gallstone disease history in Taiwan. "
01/01/2023 - "The aim of this study was to determine the role of the Taq1B CETP polymorphism with serum lipids, anthropometric variables, and the extent of steatosis in Mexican-mestizo women with gallstone disease (GD). "
08/01/2022 - "Causal associations between changes in lipid profiles and risk of gallstone disease: a two-sample Mendelian randomization study."
08/01/2021 - "In total, 816 patients with gallstone disease and 818 control participants were included in the study, and their serum lipid levels were measured. "
11/21/2013 - "To test this hypothesis, the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study as part of the Population Architecture using Genomics and Epidemiology (PAGE) study performed tests of association between 49 GWAS-identified lipid trait SNPs and gallstone disease in non-Hispanic whites (446 cases and 1,962 controls), non-Hispanic blacks (179 cases and 1,540 controls), and Mexican Americans (227 cases and 1,478 controls) ascertained for the population-based Third National Health and Nutrition Examination Survey (NHANES III). "

09/01/2003 - "To establish a rapid and precise detective method of 33.5 kd vesicular protein and to screen an effective treatment of cholelithiasis. "
01/01/1978 - "These results suggest that a hypocaloric diet associated with a low intake of fat and protein mostly of vegetable origin, is protective against cholelithiasis."
07/01/1979 - "The results of this study suggest a possible relationship between cholelithiasis and a low intake of energy, protein, fat or crude fiber, but more than one of these nutrients could be involved. "
01/01/2021 - "Protein plugs or cholelithiasis were identified by IOC in 8 children and by one-stop MRI in 45 children (P = 0.0233). "
01/01/2013 - "Role of these proteins in the etiopathogenesis of cholelithiasis remains unknown. "

01/01/2017 - "This study established that altered bile composition in patients with cholelithiasis may influence TC quantity within the gallbladder muscle, and we concluded that reduction in TC number may be a consequence of the supersaturated bile toxicity, while some other bile components (ω-3 PUFA, glycocholic, and taurocholic acids) may exert protective effects on TC and thus possibly influence the mechanisms regulating gallbladder and extrahepatic bile duct motility. "
06/01/1991 - "Specially selected 78 patients with cholelithiasis received drugs of chenodeoxycholic and ursodeoxycholic acids. "
01/01/1987 - "[Drug treatment of cholelithiasis with chenodeoxycholic and ursodeoxycholic acids (review of the foreign literature)]."
01/01/1977 - "[Treatment of cholelithiasis with chenodeaxycholic acid]."
10/11/1963 - "ORNITHOCHOLANIC ACIDS AND CHOLELITHIASIS IN MAN."

09/01/1998 - "Conflicting results on the relationship between gallstone disease and the use of nonsteroidal antiinflammatory drugs (NSAIDs) have been reported, but studies on the effect of NSAID use in populations not selected on the basis of a high risk for gallstone development are still lacking. "
09/01/1998 - "On logistic regression analysis only female gender, aging, and family history of gallstone disease were significantly associated with the presence of gallstones, whereas no relationship between NSAID use and gallstone disease was found. "
01/01/2021 - "pylori infection, histories of MS, NSAIDs use, cholelithiasis, and erosive gastritis appear to be the risk factors for EPBR, and our favorable prediction model might be an option for the prediction of EPBR."
01/01/2021 - "pylori infection status [OR (95% CI) = 2.34 (1.37-4.01), P = 0.002], MS [OR (95% CI) = 3.14 (1.77-5.54), P < 0.001], NSAIDs use history [OR (95% CI) = 1.87 (1.03-3.40), P = 0.04], cholelithiasis history [OR (95% CI) = 3.95 (2.18-7.18), P < 0.001] and erosive gastritis history [OR (95% CI) = 6.77 (3.73-12.29), P < 0.001] were the risk factors for the occurrence of EPBR. "
09/01/1998 - "Chronic NSAID ingestion does not seem to prevent gallstones in arthritis patients; in these patients gallstone disease is associated with classic risk factors (female gender and age)."

08/01/2022 - "However, in the treatment of uncomplicated cholelithiasis, prophylactic use of antibiotics is controversial. "
05/01/2019 - "Rates of infectious complications were comparable among patients receiving antibiotic agents or no antibiotic agents (8% vs. 9%, respectively; p = 0.779); also when analysis only included patients with complicated gallstone disease (11% vs. 10% respectively, p = 0.861). "
05/01/2019 - "Of 481 patients, 295 (61.3%) had uncomplicated gallstone disease and 239 (49.7%) received antibiotic treatment. "
01/30/1954 - "[Antibiotics in cholelithiasis]."
09/01/1992 - "Efficacy of topical antibiotics in cholecystectomy for gallstone disease was evaluated. "

01/01/1995 - "This study reveals that laparoscopic cholecystectomy is the most effective treatment of the large majority of patients with symptomatic cholelithiasis. "
01/01/2022 - "Introduction Laparoscopic cholecystectomy (LC), the gold standard treatment for symptomatic gallstone disease, is the most common procedure performed by general surgeons worldwide. "
09/17/2021 - "Laparoscopic cholecystectomy (LC) is the gold standard for the treatment of cholelithiasis in most countries of the world. "
07/01/2007 - "Laparoscopic cholecystectomy was highly effective in cases of symptomatic cholelithiasis. "
04/01/2001 - "Both open and laparoscopic cholecystectomy are highly safe and effective procedures for patients with symptomatic cholelithiasis. "

01/01/2006 - "Cholecystectomy is a safe and most effective procedure that provides ultimate cure for symptomatic gallstone disease."
08/01/1993 - "These data indicate that open cholecystectomy currently is a very safe, effective treatment for cholelithiasis and is being performed with near zero mortality. "
03/01/2014 - "The aim of this study was to compare the efficacy of a wait-and-see policy versus cholecystectomy after ES for CBD stones in high-risk patients with co-existing cholelithiasis. "
01/01/1990 - "We concluded that cholecystectomy is a definitive treatment for symptomatic cholelithiasis with minimal risk to the patient and a high degree of relief from symptoms. "
05/23/2012 - "There is wide variation among hospitals in the management of gallstone disease and an association between higher hospital volume and better outcome after a cholecystectomy. "

10/01/1997 - "We conclude that LC is today the treatment of choice for symptomatic cholelithiasis and is replacing OC as the gold standard against which new therapies should be compared."
07/01/1993 - "Current efforts are being directed toward closer surveillance and discovery of cholelithiasis, and improved outcomes of therapy have been aided by the development of "minimally invasive" approaches to the treatment of cholelithiasis in the elderly."
11/01/1983 - "[Evaluation of the efficacy of stone expulsion therapy in cholelithiasis with combined Chinese and western medicine]."
11/01/2009 - "The results of the study suggest a higher efficiency of combined therapy and reduced risk of development of cholelithiasis."
07/01/2003 - "Indications include the study of healthy subjects and of patients during pathophysiologically relevant conditions; in particular when subjects are at risk for gallbladder stasis and gallstone disease or during gallstone disease when a decision concerning medical dissolution therapy is required."

01/01/2011 - "Percutaneous treatment of cholelithiasis by monotherapy was effective in 89.8% of the patients, in 10% of the patients distant lithotripsy was performed for residual stones. "
03/01/2022 - "A propensity score matching study between conventional and soft fiber-optic choledochoscope guided percutaneous transhepatic cholangioscopic lithotripsy for treatment of cholelithiasis."
12/01/2021 - "In this systematic review (SRs), we searched six Chinese or international databases to collect randomized controlled clinical trials (RCTs) of TCM in preventing the recurrence of cholelithiasis after gallbladder-preserving lithotripsy. "
02/01/2023 - "Endoscopic Treatment of Acute Cholelithiasis Using AXIOS Stenting and Lithotripsy: A Case Series."
03/01/2022 - "Percutaneous transhepatic cholangioscopic lithotripsy (PTCSL) provides an alternative method for cholelithiasis treatment. "

01/01/2005 - "The present study is a retrospective analysis of 166 patients who underwent surgery because of symptomatic cholelithiasis in a three-year period; all patients underwent elective LC in ordinary hospital-stay. "
06/01/2022 - "The primary outcomes were incidence and management of gallstone disease, while secondary outcomes studied included length of stay, readmission rate, and recurrence. "
01/01/2016 - "To develop the protocol of surgical management of cholelithiasis in short-stay hospital. "
04/01/2013 - "Data from the Swedish National Patient Register and the Cause of Death Register 1988-2006 comprising hospital stays with a primary diagnosis of gallbladder/gallstone disease in Sweden were retrieved. "
06/01/2012 - "Complex gallstone disease is associated with greater risk of morbidity, associated with operative complications and longer hospital stays. "